Invention Grant
- Patent Title: Soluble and immunoreactive Zika virus NS1 polypeptides comprising the wing domain
-
Application No.: US16663417Application Date: 2019-10-25
-
Publication No.: US11312750B2Publication Date: 2022-04-26
- Inventor: Elke Faatz , Mario Gloeck , Peter Muench , Alexander Riedel , Christian Scholz , Gloria Tabares
- Applicant: Roche Diagnostics Operations, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Agency: Stinson LLP
- Priority: EP17168197 20170426
- Main IPC: C07K14/005
- IPC: C07K14/005 ; C07K14/18 ; C12N7/00 ; G01N33/569

Abstract:
The disclosure concerns a polypeptide suitable for detecting antibodies against Zika virus in an isolated biological sample having a Zika virus NS1 wing domain specific amino acid sequence and variants thereof, wherein no further Zika virus specific amino acid sequences are present in the polypeptide. This polypeptide does not immunologically cross-react with antibodies raised against structurally related antigens from tick-borne encephalitis virus, Dengue virus 1-4, West Nile virus, yellow fever virus or Japanese encephalitis virus, but immunologically reacts with antibodies raised against full length Zika virus NS1 antigen. Also disclosed is a method of producing a soluble and immunoreactive Zika virus NS1 polypeptide as well as methods and kits for detecting antibodies specific for Zika virus in an isolated sample.
Public/Granted literature
- US20200048312A1 SOLUBLE AND IMMUNOREACTIVE ZIKA VIRUS NS1 POLYPEPTIDES Public/Granted day:2020-02-13
Information query